Does IXEKIZUMAB Cause Injection site rash? 526 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 526 reports of Injection site rash have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.6% of all adverse event reports for IXEKIZUMAB.
526
Reports of Injection site rash with IXEKIZUMAB
1.6%
of all IXEKIZUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Injection site rash From IXEKIZUMAB?
Of the 526 reports, 10 (1.9%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Injection site rash Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 526 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
CERTOLIZUMAB PEGOL (360)
Which IXEKIZUMAB Alternatives Have Lower Injection site rash Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID